Working within the Design Space: Do Our Static Process Characterization Methods Suffice?

Abstract

The Process Analytical Technology initiative and Quality by Design paradigm have led to changes in the guidelines and views of how to develop drug manufacturing processes. On this occasion the concept of the design space, which describes the impact of process parameters and material attributes on the attributes of the product, was introduced in the ICH Q8 guideline. The way the design space is defined and can be presented for regulatory approval seems to be left to the applicants, among who at least a consensus on how to characterize the design space seems to have evolved. The large majority of design spaces described in publications seem to follow a “static” statistical experimentation and modeling approach. Given that temporal deviations in the process parameters (i.e., moving within the design space) are of a dynamic nature, static approaches might not suffice for the consideration of the implications of variations in the values of the process parameters. In this paper, different forms of design space representations are discussed and the current consensus is challenged, which in turn, establishes the need for a dynamic representation and characterization of the design space. Subsequently, selected approaches for a dynamic representation, characterization and validation which are proposed in the literature are discussed, also showcasing the opportunity to integrate the activities of process characterization, process monitoring and process control strategy development.

Obey validity limits of data-driven models through topological data analysis and one-class classification

“…Besides industry applications, promising future work also includes the application to optimization problems occurring in molecular design where molecules are parameterized through graph neural networks (Schweidtmann et al 2020c) or autoencoders (Jin et al 2018). Also, time-dependent design space descriptions are desired in pharmaceutics (von Stosch et al 2020). The proposed method can also be extended by considering and comparing other one-class classification methods.…”

Process evolution in cell and gene therapy from discovery to commercialization

“…Although beyond the scope of this commentary, statistical frameworks for the design space optimization exist in other fields and may be applicable to CGT. [ 20,21 ]…”

Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design

“… Risk control—includes decision making for risk reduction and risk acceptance. To systematically control the risk of failure, the following QbD concepts are employed: the definition of the appropriate static or dynamic Design space (DSp) [ 23 ] to model and describe how CMAs and CPPs affect CQAs; the implementation of Process Analytical Technology (PAT) tools to monitor the manufacturing process; the setting up of the control strategy. Risk communication—the output/result of the QRM should be appropriately communicated and documented among all involved participants (regulators, industry, patients, etc.).…”